1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Radiopharmaceutical Theranostics Market – by Product Type

1.3.2        South & Central America Radiopharmaceutical Theranostics Market – by Radioisotope

1.3.3        South & Central America Radiopharmaceutical Theranostics Market – by Source

1.3.4        South & Central America Radiopharmaceutical Theranostics Market – by Application

1.3.5        South & Central America Radiopharmaceutical Theranostics Market – by Indication

1.3.6        South & Central America Radiopharmaceutical Theranostics Market – by End User

1.3.7        South & Central America Radiopharmaceutical Theranostics Market – by Country

2.           South & Central America Radiopharmaceutical Theranostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South & Central America Radiopharmaceutical Theranostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America PEST Analysis

4.3         Expert’s Opinion

5.           South & Central America Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidence of Cancer

5.1.2        Rising Application in Treatment of Cardiovascular Disorders

5.2         Market Restraints

5.2.1        Regulatory Challenges for Approval of Radiopharmaceutical Theranostics

5.3         Market Opportunities

5.3.1        Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies

5.4         Future Trends

5.4.1        Radiopharmaceutical Theranostics in Nuclear Medicine

5.5         Impact Analysis

6.           Radiopharmaceutical Theranostics Market – South & Central America Analysis

6.1         South & Central America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7.           South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

7.2.1        Positron Emission Tomography (PET) Tracers

7.2.1.1          Overview

7.2.1.2          Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2        Beta Emitters

7.2.2.1          Overview

7.2.2.2          Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.3        Alpha Emitters

7.2.3.1          Overview

7.2.3.2          Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           South & Central America Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1         Overview

8.2         Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)

8.2.1        Technetium-99

8.2.1.1          Overview

8.2.1.2          Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.2        Gallium-68

8.2.2.1          Overview

8.2.2.2          Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.3        Iodine-131

8.2.3.1          Overview

8.2.3.2          Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4        Iodine-123

8.2.4.1          Overview

8.2.4.2          Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.5        Fluorine-18 (18F)

8.2.5.1          Overview

8.2.5.2          Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.6        Yttrium 90 (Y-90)

8.2.6.1          Overview

8.2.6.2          Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.7        Lutetium (LU) 177

8.2.7.1          Overview

8.2.7.2          Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.8        Copper (CU) 67

8.2.8.1          Overview

8.2.8.2          Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.9        Copper (CU) 64

8.2.9.1          Overview

8.2.9.2          Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.10     Others

8.2.10.1       Overview

8.2.10.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           South & Central America Radiopharmaceutical Theranostics Market Analysis – by Source

9.1         Overview

9.2         Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)

9.2.1        Nuclear Reactors

9.2.1.1          Overview

9.2.1.2          Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.2        Cyclotrons

9.2.2.1          Overview

9.2.2.2          Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        South & Central America Radiopharmaceutical Theranostics Market Analysis – by Application

10.1      Overview

10.2      Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)

10.2.1     Targeted Therapeutic (Rx)

10.2.1.1       Overview

10.2.1.2       Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2     Companion Diagnostic (CDx)

10.2.2.1       Overview

10.2.2.2       Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        South & Central America Radiopharmaceutical Theranostics Market Analysis – by Indication

11.1      Overview

11.2      Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)

11.2.1     Oncology

11.2.1.1       Overview

11.2.1.2       Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.2     Neurology

11.2.2.1       Overview

11.2.2.2       Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3     Cardiology

11.2.3.1       Overview

11.2.3.2       Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.4     Others

11.2.4.1       Overview

11.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.        South & Central America Radiopharmaceutical Theranostics Market Analysis – by End User

12.1      Overview

12.2      Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)

12.2.1     Hospitals

12.2.1.1       Overview

12.2.1.2       Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.2     Diagnostic Imaging Centers

12.2.2.1       Overview

12.2.2.2       Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3     Academic & Research Institutes

12.2.3.1       Overview

12.2.3.2       Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.4     Others

12.2.4.1       Overview

12.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.        South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis

13.1      South & Central America Radiopharmaceutical Theranostics Market

13.1.1     Overview

13.1.2     South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

13.1.2.1       Brazil: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1       Overview

13.1.2.1.2       Brazil Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3       Brazil Radiopharmaceutical Theranostics Market, by Product type, 2019–2028 (US$ Million)

13.1.2.1.4       Brazil Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.1.5       Brazil Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.1.6       Brazil Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.1.7       Brazil Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.1.8       Brazil Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.2       Argentina: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1       Overview

13.1.2.2.2       Argentina Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3       Argentina Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.2.4       Argentina Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.2.5       Argentina Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.2.6       Argentina Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.2.7       Argentina Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.2.8       Argentina Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.2.3       Rest of South & Central America: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1       Overview

13.1.2.3.2       Rest of South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3       Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.2.3.4       Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.2.3.5       Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.2.3.6       Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.2.3.7       Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.2.3.8       Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

14.        Radiopharmaceutical Theranostics Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Radiopharmaceutical Theranostics Market

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        Company Profiles

15.1      Bayer AG

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      Curium

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Telix Pharmaceuticals Ltd.

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Siemens Healthineers AG

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil Radiopharmaceutical Theranostics Market, by Product type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Argentina Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Argentina Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Argentina Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of South & Central America Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 20.          Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 21.          Glossary of Terms

LIST OF FIGURES

Figure 1.           South & Central America Radiopharmaceutical Theranostics Market Segmentation

Figure 2.           South & Central America Radiopharmaceutical Theranostics Market, by Country

Figure 3.           South & Central America Radiopharmaceutical Theranostics Market Overview

Figure 4.           Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market

Figure 5.           Brazil Expected to Show Remarkable Growth During Forecast Period

Figure 6.           South & Central America: PEST Analysis

Figure 7.           South & Central America Experts’ Opinion

Figure 8.           South & Central America Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           South & Central America Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        South & Central America Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Positron Emission Tomography (PET) Tracers: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Beta Emitters: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Alpha Emitters: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        South & Central America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)

Figure 15.        Technetium-99: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Gallium-68: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Iodine-131: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Iodine-123: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Fluorine-18 (18F): South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Yttrium 90 (Y-90): South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lutetium (LU) 177: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Copper (CU) 67: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Copper (CU) 64: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        South & Central America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)

Figure 26.        Nuclear Reactors: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cyclotrons: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        South & Central America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)

Figure 29.        Targeted Therapeutics (Rx): South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Companion Diagnostics (CDx): South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        South & Central America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)

Figure 32.        Oncology: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Neurology: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cardiology: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        South & Central America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)

Figure 37.        Hospitals: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Diagnostic Imaging Centers: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Academic & Research Institutes: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        Others: South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        South & Central America: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 42.        South & Central America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

Figure 43.        Brazil Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Argentina Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Rest of South & Central America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Growth Strategies in the Radiopharmaceutical Theranostics Market